Although the concept of selective delivery has been postulated over 100 years ago, no
targeted nanomedicine has been clinically approved so far. Nanoparticles modified with …

Circulating tumour cells (CTCs) have recently been identified as valuable biomarkers for
diagnostic and prognostic evaluations, as well for monitoring therapeutic responses to …

Antibody-functionalized nanoparticles (NPs) are commonly used to increase the targeting
selectivity toward cells of interest. At a molecular level, the number of functional antibodies …

In developing countries, there are often limited resources available to provide important
medical diagnostics, which severely limits our ability to diagnose conditions and administer …

Progress in cell purification technology is critical to increase the availability of viable cells for
therapeutic, diagnostic, and research applications. A variety of techniques are now available …

There is growing awareness for the need of early diagnostic tools to aid in point-of-care
testing in cancer. Tumor biopsy remains the conventional means in which to sample a tumor …

Apoptosis is an interactive and dynamic biological process involved in all phases of
embryogenesis. We aimed to study the effect of placental apoptosis on recurrent miscarriage …

Targeted photopolymerization is the basis for multiple diagnostic and cell encapsulation
technologies. While eosin is used in conjunction with tertiary amines as a water-soluble …

Cancer stem cells (CSCs) are of fundamental importance in tumor progression because of
their tumor-initiating properties, their resistance to radio-and chemotherapy, their invasive …

The development of multivalent nanoprobes has garnered considerable interest due to their
enhanced sensitivity and precision in diagnosing and monitoring diverse diseases. Despite …